March 26, 2019
Innovation at REV.1 Engineering

Identifying and Managing Strategic Dollars in Device Development

Developing a medical device to commercialization is a complex, multi-faceted endeavor.  It’s also an expensive undertaking fraught with risk factors at each stage of development. While maintaining a meticulous attention to detail is paramount throughout the entire process, the fact of the matter is, some of the dollars you’ll be spending will inevitably be more strategic than others. Strategic dollars drive two areas of value creation.  First, strategic dollars intermediate critical risk factors from metastasizing […]
January 3, 2019

REV.1 Engineering Medical Device Client Closes on $77 Million Series D Round

Ablative Solutions (Kalamazoo, MI) announces major investment in support of their innovative device technology intended for the treatment of hypertension. MURRIETA, Calif. – Jan. 3, 2019 – PRLog — REV.1 Engineering is pleased to announce one of their long-standing, medical device development clients, Ablative Solutions (ASI), closed on $77 million in Series D equity financing today. “We’re very excited for this significant achievement for our friends at Ablative Solutions,” said Eric Johnson, CEO of REV.1 Engineering.  “It’s also a reflection of […]
June 1, 2017
REV.1 Engineering Team

Client Collaboration in Outsourced Medical Device Development

We were thinking about the expression, “When I tell you to jump, you say, ‘How high?’” The intent of this expression is clearly “Do what you’re told,” and we often encounter clients that approach outsourcing in the same fashion. Rather than approaching a partner company from a collaborative standpoint, they believe they have to control every step. Exerting excessive control is usually a response to managing the unknown. Often a client’s fears of entering a […]
May 11, 2017
FEA Graphic

Medical Device Design Case Study: Unique FEA Modeling Techniques Support R&D

We recently assisted a Southern California biotechnology company that is developing a novel immunotherapy for treating cancer. Immunotherapy is an exciting emerging field and we were happy to be involved in this potential game-changing technology. This client had strong intellectual property and a strong team of scientists with deep experience and expertise. They came to us with a need to deliver a biologic payload to a target in tissue – and to combine the payload […]
X
Schedule a Conversation
Contact Us